GB920416A - Piperazino compounds - Google Patents

Piperazino compounds

Info

Publication number
GB920416A
GB920416A GB1120059A GB1120059A GB920416A GB 920416 A GB920416 A GB 920416A GB 1120059 A GB1120059 A GB 1120059A GB 1120059 A GB1120059 A GB 1120059A GB 920416 A GB920416 A GB 920416A
Authority
GB
United Kingdom
Prior art keywords
lower alkyl
group
formula
compound
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1120059A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAKESIDE LAB Inc
Original Assignee
LAKESIDE LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US728513A external-priority patent/US2993900A/en
Application filed by LAKESIDE LAB Inc filed Critical LAKESIDE LAB Inc
Publication of GB920416A publication Critical patent/GB920416A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises piperazines of the general formula (I): <FORM:0920416/IV(a)/1> and non-toxic acid addition including penicillin and quaternary ammonium salts thereof wherein R1 and R2 is phenyl, lower alkylphenyl, halophenyl, lower alkoxy-phenyl, alkylenedioxyphenyl, thienyl, furyl, pyridyl or cycloalkyl groups and when R1 and R2 are both phenyl they may be joined by a carbon to carbon bond in the 2-position and when R2 is furyl, R1 can be propyl, R3, R13, R113 and R1113 is hydrogen or a lower alkyl group, R4 is a lower alkyl, aralkyl, aryl, aralkenyl, lower alkoxy- or halo-substituted aralkyl alkenyl group, A is hydroxy or halogen, Y is a lower alkylene group, and when both R1 and R2 are phenyl, R4 and Y are not methyl and ethylene, respectively, piperazines of the general formula (II): <FORM:0920416/IV(a)/2> and acid addition salts thereof, wherein R5 is a phenyl, thienyl, pyridyl, or cyclohexyl group, R6 is a phenyl, thienyl, furyl, cyclohexyl, cyclopentyl, or lower alkyl group, R3, R13, R113, R1113 is hydrogen or a lower alkyl group. R7 is hydrogen or an acyl or benzyl group, A is hydroxy or halogen and Y1 and Y11 are lower alkylene groups of at least 2 carbons each; a process for the preparation of compounds (I) by (a) reacting an acid derivative of the formula: <FORM:0920416/IV(a)/3> with a piperazine alkanol of the formula: <FORM:0920416/IV(a)/4> wherein R8 is lower alkyl, Z is a reactive halogen, and X is halogen, and, if required, hydrolysing the reaction product when A is halogen to form the hydroxy derivative; or (b) reacting an acid of the formula: <FORM:0920416/IV(a)/5> with a piperazine: <FORM:0920416/IV(a)/6> wherein Z is a reactive halogen; a process which comprises reacting a compound of the formula: <FORM:0920416/IV(a)/7> with 9-hydroxyfluorene-9-carboxylic acid or a lower alkyl ester thereof to form the corresponding ester wherein Z is a halogen atom R14 is a lower alkyl, aralkyl, hydroxyalkyl, acyloxyalkyl, acyloxyalkoxyalkyl, hydroxyalkoxyalkyl, alkoxyalkyl, benzyloxyalkoxyalkyl or benzyloxyalkyl group and when the lower alkyl ester is used in the reaction R14 may be acyloxyalkyl and may not be hydroxyalkyl except that the hydroxy groups on the hydroxyalkyl group are esterified or etherified to block it during the reaction and subsequently regenerated; a process for preparing compounds of the general formula II (A=OH; R7=H) either by reacting a compound of the formula: <FORM:0920416/IV(a)/8> with a compound: <FORM:0920416/IV(a)/9> wherein R9 and R10 have the same meanings as R5 and R6 respectively and R8 is a lower alkyl group and catalytically hydrogenating the compound to remove the hydrocarbon aryl group or by reacting a compound of the formula: <FORM:0920416/IV(a)/100> with a compound: <FORM:0920416/IV(a)/111> wherein Z and Z1 are reactive halogen atoms and hydrolysing the compound formed thereby. 4-Cinnamyl-piperazinoethanol is prepared from cinnamyl chloride and hydroxyethylpiperazine; 4 - beta-benzyloxyethylpiperazinoethanol is similarly prepared. Pharmaceutical compositions comprise the compounds of the invention and a suitable pharmaceutical carrier and may be formulated as powders, tablets or capsules. The compounds of the invention form salts with penicillin and may be used to isolate penicillin from fermentation broths and other solutions of the antibiotic.
GB1120059A 1958-04-04 1959-04-02 Piperazino compounds Expired GB920416A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US72634758A 1958-04-04 1958-04-04
US72808558A 1958-04-14 1958-04-14
US728513A US2993900A (en) 1958-04-15 1958-04-15 4-hydroxyalkylpiperazinoalkyl glycolates
US73535658A 1958-05-15 1958-05-15
US76594058A 1958-10-08 1958-10-08
US76804258A 1958-10-20 1958-10-20

Publications (1)

Publication Number Publication Date
GB920416A true GB920416A (en) 1963-03-06

Family

ID=27560258

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1120059A Expired GB920416A (en) 1958-04-04 1959-04-02 Piperazino compounds

Country Status (1)

Country Link
GB (1) GB920416A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089922A2 (en) * 1998-06-30 2004-10-21 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6943168B2 (en) 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6949554B2 (en) 1998-06-30 2005-09-27 Neuromed Technologies Inc. Calcium channel blockers comprising two benzhydril moieties
US7186726B2 (en) 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089922A2 (en) * 1998-06-30 2004-10-21 Neuromed Technologies, Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
WO2004089922A3 (en) * 1998-06-30 2005-03-24 Neuromed Tech Inc Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6943168B2 (en) 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6949554B2 (en) 1998-06-30 2005-09-27 Neuromed Technologies Inc. Calcium channel blockers comprising two benzhydril moieties
US6951862B2 (en) 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US7064128B2 (en) 1998-06-30 2006-06-20 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
US7186726B2 (en) 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers

Similar Documents

Publication Publication Date Title
GB1014053A (en) 7-hydroxy-coumarin derivatives and process for their production
GB973361A (en) Pyrazolo-pyrimidines and process for their manufacture
ES8308548A1 (en) Piperazine substituted carboxamide derivatives, compositions and method of use
GB920416A (en) Piperazino compounds
ES8302463A1 (en) Soft tertiary amine esters of bio-affecting carboxylic acids, processes for preparing and a pharmaceutical composition containing the same.
IE782499L (en) Anticolinergics
GB1041536A (en) Quaternary ammonium derivatives of dibenzo[a,d]-cycloheptadiene derivatives
GB1414207A (en) Benzo b thiophene derivatives their preparation and use as pharmaceuticals
DE3373652D1 (en) Carboximide derivatives, process for their production and medicines containing same
GB991589A (en) Novel [1,2-ª‡]imidazopyridines and a process for the manufacture thereof
GB831920A (en) New phenthiazine derivatives and processes for their preparation
GB804193A (en) Improvements in or relating to iminodibenzyl compounds
GB776717A (en) Derivatives of mandelic acid and their salts and process for the preparation thereof
GB1024643A (en) Optically active naphthalene derivatives
ES385640A2 (en) Carbamoyl oximes
US3028390A (en) Substituted piperazine compounds and process for producing the same
GB824536A (en) Improvements in or relating to new phenthiazine derivatives and processes for their preparation
ES8200689A1 (en) Acylated cephalosporin analogs, process for their preparation and pharmaceutical compositions comprising them.
ES301524A1 (en) Procedure for the preparation of antivirus compositions in a unit dosage form (Machine-translation by Google Translate, not legally binding)
ES442710A1 (en) A procedure for preparing new piperazine derivatives. (Machine-translation by Google Translate, not legally binding)
GB1023207A (en) Basic acid esters of heterocyclic alcohols, compositions thereof, and method of making and using
ES404882A1 (en) Derivatives of 9-oxo-13-trans-prostenoic acid esters
GB840824A (en) Novel derivatives of piperidine carboxylic acids and process for preparing same
GB952591A (en) Derivatives of 4:4-bis(4-hydroxyphenyl)-pentanoic acid and methods of preparing the same
GB936764A (en) Piperazino compounds